Article Versions Notes

Kühn JP, Schmid W, Körner S, Bochen F, Wemmert S, Rimbach H, Smola S, Radosa JC, Wagner M, Morris LGT, et al. HPV Status as Prognostic Biomarker in Head and Neck Cancer—Which Method Fits the Best for Outcome Prediction? Cancers. 2021; 13(18):4730. https://doi.org/10.3390/cancers13184730

Kühn, Jan Philipp, Wendelin Schmid, Sandrina Körner, Florian Bochen, Silke Wemmert, Hugo Rimbach, Sigrun Smola, Julia Caroline Radosa, Mathias Wagner, Luc G.T. Morris, and et al. 2021. "HPV Status as Prognostic Biomarker in Head and Neck Cancer—Which Method Fits the Best for Outcome Prediction?" Cancers 13, no. 18: 4730. https://doi.org/10.3390/cancers13184730

Kühn, J. P., Schmid, W., Körner, S., Bochen, F., Wemmert, S., Rimbach, H., Smola, S., Radosa, J. C., Wagner, M., Morris, L. G. T., Bozzato, V., Bozzato, A., Schick, B., & Linxweiler, M. (2021). HPV Status as Prognostic Biomarker in Head and Neck Cancer—Which Method Fits the Best for Outcome Prediction? Cancers, 13(18), 4730. https://doi.org/10.3390/cancers13184730